Stryker achieved strong FY2025 performance with organic revenue growth of 8% and operating margin expansion through pricing realization and operational efficiency. New product introductions in joint replacement and robotic-assisted surgery drove volume growth and market share gains.
Access the complete analysis, financial model, price target breakdown, and risk factors.
Read Full Report →2 free reads per day · No credit card required